Previsioni

Non sono disponibili dati degli analisti per questa azienda.

Notizie Vai al feed delle notizie

Promino Nutritional Sciences reports 5,100% quarterly revenue increase

For the quarter ended June 30, 2025, Promino Nutritional Sciences reported revenue of CAD 0.5 million, a 5,100% increase compared with last year's CAD 0.0 million. The figures were presented at the financial conference on September 19, 2025. » Altro su finanzen.net
Promino Nutritional Sciences: Q1 EPS CAD 0.02, annual result CAD -0.09 per share and revenue decline

Promino Nutritional Sciences reported earnings per share (EPS) of CAD 0.02 for the quarter ended 31 December 2024 on quarterly revenue of CAD 0.1 million. For the full fiscal year, loss per share was CAD -0.09 versus -0.15 CAD in the prior year. Annual revenue amounted to CAD 0.26 million, a significant decline of 45.83 percent year over year. » Altro su finanzen.net
Cambridge Nutritional Sciences calls annual general meeting for 25 September

Cambridge Nutritional Sciences plc has called its annual general meeting for Thursday, 25 September 2025 at 15:00 at E-space North in Littleport, Ely and has finalised the directors’ report and financial statements for the year ended 31 March 2025. The report will be sent to shareholders next week and published on the company website; Cavendish Capital Markets Limited is acting as adviser. The company is traded on the London AIM under the ticker CNSL. » Altro su de.investing.com

Dati finanziari dell'azienda

Nell'ultimo anno, Promino Nutritional Sciences Aktie ha registrato ricavi pari a 2,75 Mln € e un utile netto di -7,11 Mln €

(EUR)	2022	YoY
Ricavi	2,75 Mln	67,66%
Utile lordo	-743,81K	711,02%
Utile netto	-7,11 Mln	16,37%
EBITDA	-6,88 Mln	14,75%

Dati fondamentali

Metrica	Valore
Capitalizzazione di mercato	7,73 Mln €
Numero di azioni	128,02 Mln
Massimo/minimo a 52 settimane	0,16 € - 0,021 €
Dividendi	No
Beta	3,09
Rapporto P/E	-0,95
Rapporto PEG	0,04
Rapporto P/B	-1,98
Rapporto P/S	2,66

Profilo aziendale

Element Nutritional Sciences Inc. ist ein Nutrazeutik-Unternehmen, das Ernährungsprodukte entwickelt. Das Unternehmen bietet Rejuvenate, eine firmeneigene Formulierung zur Unterstützung des Wiederaufbaus, der Wiederherstellung und der Verjüngung des natürlichen Verlusts an Muskelmasse aufgrund des Alterns oder anderer medizinischer Bedingungen, sowie JAKTRX-Leistungsergänzungsprodukte an. Das Unternehmen vertreibt seine Produkte auch in Geschäften und online. Das Unternehmen war früher unter dem Namen Element Nutrition Inc. bekannt und änderte im Juni 2021 seinen Namen in Element Nutritional Sciences Inc. um. Der Hauptsitz von Element Nutritional Sciences Inc. befindet sich in Burlington, Kanada.